Singh Richa, Choudhary Annu, Singh Swati, Kumar Harsh
Department of Anaesthesiology, Indira Gandhi Institute of Medical Sciences, Patna, India.
Anesth Pain Med (Seoul). 2024 Oct;19(4):310-319. doi: 10.17085/apm.24105. Epub 2024 Oct 31.
The ideal anesthetic drug choice for local infiltration anesthesia under monitored anesthesia care must provide analgesia and patients' comfort along with a bloodless surgical field for patients. We hypothesized that dexemedetomidine can provide better visibility of the surgical field at a higher dose of 1 µg/kg than 0.5 µg/kg, along with providing sedation and analgesia.
After institutional ethics committee clearance and written informed consent, this prospective, randomized, triple blind study was conducted on ninety patients, between 18- 65 years who were scheduled for tympanoplasty. The patients were randomly assigned to either the dexmedetomidine (DEX) 0.5 group or the DEX 1.0 group, and received 10 ml solution containing 2% lignocaine with 0.5 µg/kg dexmedetomidine, or the 1 µg/kg dexmedetomidine. The operative surgeon performed local infiltration using standardized 5-point infiltration technique around the auricle. The primary objective was to compare the intraoperative bleeding at the surgical site. The comparison of normally distributed variables was conducted using the Student's t-test, whereas non-normally distributed variables was compared using the Mann-Whitney U test. The analysis of qualitative data was conducted using the chisquare/Fisher's exact test. A P value less than 0.05 was considered statistically significant.
The overall bleeding score was significantly higher in the DEX 0.5 group (3.21 ± 0.727) than the DEX 1.0 group (1.43 ± 0.661) (P value < 0.001). The time to first analgesic requirement and surgeon satisfaction score were also significantly higher in the DEX 1.0 group.
Combining dexmedetomidine at a dose of 1 µg/kg with 2% lignocaine for infiltration provided improved analgesia and improved the surgical field during tympanoplasty performed under monitored anesthesia care.
在监护麻醉下进行局部浸润麻醉时,理想的麻醉药物选择必须为患者提供镇痛、舒适感以及无血的手术视野。我们假设,与0.5μg/kg的剂量相比,右美托咪定在1μg/kg的较高剂量下能够提供更好的手术视野可视性,同时提供镇静和镇痛作用。
经机构伦理委员会批准并获得书面知情同意后,对90例年龄在18至65岁、计划进行鼓室成形术的患者进行了这项前瞻性、随机、三盲研究。患者被随机分为右美托咪定(DEX)0.5组或DEX 1.0组,分别接受含有2%利多卡因和0.5μg/kg右美托咪定的10ml溶液,或1μg/kg右美托咪定。手术医生采用标准化的五点浸润技术在耳廓周围进行局部浸润。主要目的是比较手术部位的术中出血情况。对正态分布变量的比较采用Student t检验,而非正态分布变量则采用Mann-Whitney U检验。定性数据的分析采用卡方/费舍尔精确检验。P值小于0.05被认为具有统计学意义。
DEX 0.5组的总体出血评分(3.21±0.727)显著高于DEX 1.0组(1.43±0.661)(P值<0.001)。DEX 1.0组首次需要镇痛的时间和手术医生满意度评分也显著更高。
在监护麻醉下进行鼓室成形术时,将1μg/kg剂量的右美托咪定与2%利多卡因联合用于浸润可提供更好的镇痛效果,并改善手术视野。